Express Pharma
Home  »  Pharma Ally  »  LANXESS appoints Dr Jens-Christian Blad as new head of corporate development

LANXESS appoints Dr Jens-Christian Blad as new head of corporate development

Read Article

Dr Blad will assume the role by September 1, 2017

Dr Jens-Christian Blad

Specialty chemicals company LANXESS has appointed a new head of Corporate Development. Dr Jens-Christian Blad will assume responsibility for the group function by September 1, 2017.

Blad studied chemistry in Kiel, obtained his doctorate in Muenster and is regarded by many in the industry as a specialty chemicals expert. He has been with the global management consulting firm McKinsey & Company since 2006, where he is in charge of the ‘Megatrends-supported growth in chemicals’ initiative and a member of the Chemicals Practice.

Following the closing of the acquisition of US-based chemical company Chemtura, the current head of corporate development, Dr Markus Eckert, has assumed responsibility for the new Urethane Systems business unit. Until his successor begins his new role, Eckert will remain responsible for the group function, in addition to his new role.

“I am delighted we have secured the appointment of Jens-Christian Blad, a recognised industry expert and an experienced consultant, to lead the group function and help us press ahead with our realignment,” said Matthias Zachert, Board of Management Chairman, LANXESS. “On behalf of the Board of Management, I would like to thank Eckert for his outstanding work and wish him continued success in his new area of responsibility,” he added.

Comments are closed.